Products for Research Use Only
RegisterLogin

TRK-IN-18

CAT: 0804-HY-146524Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-146524Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
TRK-IN-18 is a potent inhibitor of TRK. Tropomyosin-related kinases (Trks) are a family of receptor tyrosine kinases activated by neurotrophins, a group of soluble growth factors including Nerve Growth Factor (NGF), Brain-Derived Neurotrophic Factor (BDNF) and Neurotrophin-3 (NT-3) and Neurotrophin-4/5 (NT-4/5) . TRK-IN-18 has the potential for the research of cancer diseases (extracted from patent WO2021148805A1, compound 7) [1].
CAS Number
2412008-91-2
UNSPSC
12352005
Target
Trk Receptor
Type
Reference compound
Related Pathways
Neuronal Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/trk-in-18.html
Solubility
10 mM in DMSO
Smiles
CSC1=C(C=C(C=C1)F)[C@H]2C[C@@H](CN2C3=NN4C(C(NCC5=CC(O)=CC=C5)=O)=CN=C4C=C3)F
Molecular Formula
C25H23F2N5O2S
Molecular Weight
495.54
References & Citations
[1]Nicola ROBAS, et al. Topical pharmaceutical compositions comprising imidazo[1,2-b]pyridazine compounds. Paatent WO2021148805A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-144451TRK-IN-12
HY-146519TRK-IN-14
HY-160166TRK-IN-26
HY-146521TRK-IN-15
HY-12327Trk-IN-1
HY-144423Trk-IN-10
HY-160165TRK-IN-25
HY-149965TRK-IN-23
HY-161179TRK-IN-27
HY-161819TRK-IN-29

Alternative Products

CatalogName
T63346-01TRK-IN-18
338192-01Trk A
PA1321-STrk-A
GTR18303659Trk Antibody
T212244-01TRK-IN-32
T211064-01TRK-IN-31
T210169-01TRK-IN-29
T209555-01TRK-IN-22
T87568-01TRK-IN-25
T62561-01TRK-IN-17

Popular Products